Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 9, 2016

Total Value ($000): $396,866 (100.0% shares, 0.0% debt)

Holdings (10)

— ABIOMED INC 39.9%

Value ($000) $158,471 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— ENTELLUS MED INC 17.6%

Value ($000) $69,667 Shares 3,813,197 Est. Cost $21.90 Unrealized —

— REVANCE THERAPEUTICS INC 15.7%

Value ($000) $62,452 Shares 4,592,047 Est. Cost $31.50 Unrealized —

AXGN AXOGEN INC 8.4%

Value ($000) $33,444 Shares 4,861,111 Est. Cost $4.01 Unrealized +41.2%

— CORIUM INTL INC 8.2%

Value ($000) $32,456 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 5.6%

Value ($000) $22,174 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 2.2%

Value ($000) $8,836 Shares 1,170,370 Est. Cost $2.95 Unrealized +145.2%

LGND LIGAND PHARMACEUTICALS INC 1.0%

Value ($000) $3,923 Shares 32,893 Est. Cost $74.21 Unrealized 0.0%

ACUR ACURA PHARMACEUTICALS INC 0.9%

Value ($000) $3,619 Shares 1,956,397 Est. Cost $3.40 Unrealized -24.1%

— CATALYST BIOSCIENCES INC 0.5%

Value ($000) $1,824 Shares 1,179,352 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$158,471	39.9%	$21.56	—	COM	003654100
—	ENTELLUS MED INC	3,813,197	$69,667	17.6%	$21.90	—	COM	29363K105
—	REVANCE THERAPEUTICS INC	4,592,047	$62,452	15.7%	$31.50	—	COM	761330109
AXGN	AXOGEN INC	4,861,111	$33,444	8.4%	$4.01	+41.2%	COM	05463X106
—	CORIUM INTL INC	9,353,304	$32,456	8.2%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	1,257,468	$22,174	5.6%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$8,836	2.2%	$2.95	+145.2%	COM NEW	58468P206
LGND	LIGAND PHARMACEUTICALS INC	32,893	$3,923	1.0%	$74.21	0.0%	COM NEW	53220K504
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$3,619	0.9%	$3.40	-24.1%	COM PAR $0.01	00509L802
—	CATALYST BIOSCIENCES INC	1,179,352	$1,824	0.5%	$4.80	—	COM	14888D109